Skip to content

Clinical Trials to Validate the Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography

Validation of Clinical Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03350555
Enrollment
40
Registered
2017-11-22
Start date
2017-11-30
Completion date
2019-12-31
Last updated
2017-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ERCP

Brief summary

Validation of clinical use of additioned endoscopy in Endoscopic Retrograde Cholangiopancreatography(ERCP) treatment.

Detailed description

Investigators recently developed a device named additioned Endoscopy. The purpose of current clinical trial is to evaluate the use of additioned endoscopy in ERCP treatment, specifically in shortening the duration of ERCP operation and lowering incidence of complications.

Interventions

DEVICEAdditioned Endoscopy

To evaluate the use of additioned endoscopy in ERCP treatment.

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

One arm includes participants who will receive additioned endoscopy assisted ERCP, and the other arm includes participants who will not receive additioned endoscopy assisted ERCP.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* People who are indicated to ERCP treatment.

Exclusion criteria

* People who are not suitable for ERCP treatment.

Design outcomes

Primary

MeasureTime frameDescription
Duration of ERCP treatmentDuration of operation in each patient, ie. from beginning to the end of ERCP operation in each patientTo test if additioned endoscopy will have impact on duration of ERCP treatment

Secondary

MeasureTime frameDescription
complications of ERCP treatmentup to 1 month after ERCP completionTo test if additioned endoscopy will have impact on incidence of ERCP complications, including perforation, bleeding, post-ERCP pancreatitis.

Countries

China

Contacts

Primary ContactXiangyu Kong, MD
xiaoniu185@qq.com13564644397

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026